Please login to the form below

Not currently logged in
Email:
Password:

Pascale Richetta moves from AbbVie to UCB

She joins the biopharmaceutical company as executive vice president
Pascale Richetta

UCB has appointed Pascale Richetta to lead the global biopharmaceutical company's new bone patient value unit with effect from 1 February.

The unit was created last year with the development of UCB's patient value organisation and is currently led by its chief medical officer and head of the development of medical practices Iris Loew Friedrich.

In her new role Richetta will also serve at UCB as an executive vice president and member of the Belgium-based company's executive committee.

She has over 20 years of commercial and managerial experience in the pharmaceutical industry having worked with both traditional pharmaceuticals and complex biologics.

Richetta most recently served as vice president for Western Europe and Canada for AbbVie.

Prior to this, Richetta held managerial positions at Abbott, GSK, Ipsen and Servier where she was responsible for the international launch of each company's key drugs.

21st January 2016

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...
clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...
What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...

Infographics